Skip to content

A multicenter, randomized, parallel controlled study of low-intensity red light on myopia control in children

A multicenter, randomized, parallel controlled study of low-intensity red light on myopia control in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055402
Enrollment
Unknown
Registered
2022-01-08
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Strong intervention group:Both eyes were irradiated with low-intensity red light for 7 consecutive days in a week, twice a day, each time for 3 minutes, and the interval between two irradiations was m
Middle intervention group:From Wednesday to Sunday, use low-intensity red light to illuminate both eyes for 5 consecutive days, 2 times a day, each exposure time is 3 minutes, and the interval between
Low intervention group:The eyes were irradiated with low-intensity red light for 7 consecutive days in a week, once a day for 3 minutes
Control group :Single focus frame glasses

Sponsors

Xuzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Written informed consent signed by the child and legal guardian has been obtained. 2. Children aged 6 to 12 years, inclusive. 3. Computer optometry after cycloplegia to detect the equivalent spherical power of both eyes: -6.00D=0.8 in both eyes (logMAR 0.1; Snellen 20/25). 6. Binocular anisometropia <=1.50D. 7. Those who voluntarily gave up other treatment methods during the study period.

Exclusion criteria

Exclusion criteria: 1. Patients who may suffer from eye diseases that affect vision or refractive errors (such as cataract and other lens damage diseases, glaucoma, macular degeneration, keratopathy, uveitis, retinal detachment, severe vitreous opacity, etc.). 2. Patients with halo syndrome, cured tics, cured ADHD, and patients with psoriasis. 3. Systemic diseases: those with a history of immune system diseases, central nervous system diseases, Down syndrome, asthma, severe heart and lung function, and severe liver and kidney dysfunction. 4. Obvious strabismus or any other pathological changes of the eye or acute inflammatory diseases of the eye in both eyes. 5. Those who have used myopia control treatment methods within 3 months, drug treatment: such as atropine or pirenzepine; device treatment: orthokeratology lens, multifocal soft lens, multifocal hard lens, functional frame glasses.

Design outcomes

Primary

MeasureTime frame
axial length;mydriatic spherical equivalent;

Secondary

MeasureTime frame
uncorrected visual acuity;best corrected visual acuity;

Countries

China

Contacts

Public ContactWang Xiaojuan

Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University

153803468@qq.com+86 15852260552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026